JP Morgan Chase’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

JP Morgan Chase’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-540,000	Closed	-$93.3M	–	4366
2015 Q1	$93.3M	Buy	540,000 +464,100	+611%	+$68.1M	0.02%	654
2014 Q4	$8.72M	Buy	75,900 +67,400	+793%	+$8.16M	﹤0.01%	2045
2014 Q3	$1.33M	Sell	8,500 -491,500	-98%	-$71.3M	﹤0.01%	3169
2014 Q2	$61.7M	Buy	500,000 +6,250	+1%	+$691K	0.02%	759
2014 Q1	$51.2M	Hold	493,750	–	–	0.01%	798
2013 Q4	$44.4M	Hold	493,750	–	–	0.01%	877
2013 Q3	$33M	Buy	+493,750	New	+$34M	0.01%	1022

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

JP Morgan Chase's SLXP Position: Q2 2015 in Review

JP Morgan Chase sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 440,180 shares — an estimated $76.1M sold.

JP Morgan Chase first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $127M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

JP Morgan Chase reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
JP Morgan Chase sold 440,180 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $76.1M.
JP Morgan Chase first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
JP Morgan Chase's SALIX PHARMACEUTICALS LTD DEL position peaked at $127M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.